Beamion BCGC-1 (1479.12): A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread12
1. NCT06324357. https://clinicaltrials.gov/study/NCT06324357, accessed July, 2024 2. Boehringer Ingelheim. Data on file